Rhinosporidium seeberi

Last updated

Rhinosporidium seeberi
Scientific classification
Domain:
(unranked):
(unranked):
Class:
Order:
Family:
Dermocystidiaceae
Genus:
A. Minchin & H. Fantham, 1905 [1]
Species:
R. seeberi
Binomial name
Rhinosporidium seeberi
Synonyms
  • Coccidium seeberiWernicke 1903
  • Rhinosporidium ayyariAllen & Dave 1936
  • Rhinosporidium equiZschokke 1913
  • Rhinosporidium kinealyiMinchin & Fantham 1905

Rhinosporidium seeberi is a eukaryotic pathogen responsible for rhinosporidiosis, a disease which affects humans, horses, dogs, and to a lesser extent cattle, cats, foxes, and birds. [2] It is most commonly found in tropical areas, especially India and Sri Lanka. [2] [3]

Contents

The pathogen was first identified in 1892, and was comprehensively described in 1900 by Seeber.

Many aspects of the disease and of the pathogen Rhinosporidium seeberi remain problematic and enigmatic. These include the pathogen’s natural habitat, some aspects of its ‘lifecycle’, its immunology, some aspects of the epidemiology of the disease in humans and in animals, the reasons for the delay at in vitro culture, and establishment of disease in experimental animals, hence paucity of information on its sensitivity to drugs, and the immunology of the pathogen. Thankamani isolated an organism believed to be R. seeberi and gave the name "UMH.48." It was originally isolated from the biopsies and nasal swabs of rhinosporidiosis patients. The various developmental stages of UMH.48 showed a strong resemblance with the structures seen in hisopathological sections of rhinosporidiosis in tissue samples. The spores of UMH.48 were found to be viable even after a decade of preservation in the refrigerator without any subculture, resembling the features of Synchytrium endobioticum , a lower aquatic fungus that causes black wart disease in potatoes. However, carefully performed molecular studies showed the definitive identity of the organism. [4] [5] [6] [7]

Phylogeny

For most of the 20th century, the classification of R. seeberi was unclear (being considered either a fungus or a protist), but it was shown to be part of a group called the Mesomycetozoea [8] [9] (or "DRIP clade"), [10] which includes a number of well-known fish pathogens such as Dermocystidium and Sphaerothecum destruens . The Mesomycetozoea are neither part of the fungi nor of animals, but diverged from them close to the time when they diverged from each other. [6] [11]

Rhinosporidium is generally classified as having a single species, although some evidence indicates that different host species may be infected by different strains. [12]

Epidemiology

Infection in humans with this organism has been reported from about 70 countries, with the majority of cases (95%) reported from India and Sri Lanka; per capita, Sri Lanka has the highest incidence in the world. The disease is also found in other parts of the world. [3] [13] [14]

An all-India survey conducted in 1957 found that this disease was absent from the states of Jammu and Kashmir, Himachal Pradesh, Punjab, Haryana and the north eastern states of India. In Tamil Nadu, four endemic areas were identified in the survey—(Madurai, Ramnad, Rajapalayam, and Sivaganga). The common factor found in these areas was the practice of bathing in common ponds.

Transmission and dissemination

  1. Demellow's theory of infection [ citation needed ]
  2. Karunarathnae's autoinoculation theory [ citation needed ]
  3. Haematogenous spread – to distant sites
  4. Lymphatic spread – causing lymphadenitis (rare)

Demellow postulated that while bathing in common ponds, the nasal mucosa came into contact with infectious material. Karunarathnae proposed that the satellite lesions in skin and conjunctival mucosa arose as a result of autoinoculation.

Because of its relationship to fish pathogens, Rhinosporidium is presumed to have evolved from aquatic pathogens similar to the other Mesomycetozoea and evolved to infect mammal and bird hosts. If this happened once or more than once is unknown. [12]

Natural habitat

Karunarathnae also proposed that Rhinosporidium existed in a dimorphic state—a saprotroph in soil and water and a yeast form inside living tissues. Recent studies done using fluorescent in situ hybridization techniques provide evidence that its natural habitat is reservoir water, and perhaps, soil contaminated with this water. [15]

Pathology

One report indicates that patients with rhinosporidiosis possess anti-R. seeberi IgG to an inner wall antigen expressed only during the mature sporangial stage. This finding suggests that the mapping of antigenic proteins may lead to important antigens with the potential as vaccine candidates.

Humoral and cell-mediated immune responses in human patients and in experimental mice have been defined; several mechanisms of immune evasion by R. seeberi have been identified.

A novel method for the determination of the viability of rhinosporidial endospores by MTT-reduction led to the study of the sensitivity of endospores to biocides and antimicrobial drugs (paper in preparation for submission).

Clinical features

Image showing a large rhinosporidial mass in the oropharynx of a patient Rhinosporidiosis.jpg
Image showing a large rhinosporidial mass in the oropharynx of a patient

This organism infects the mucosa of the nasal cavity, producing a mass-like lesion. This mass appears to be polypoidal in nature with a granular surface speckled with whitish spores. The rhinosporidial mass has been classically described as a strawberry-like mulberry mass. This mass may extend from the nasal cavity into the nasopharynx and present itself in the oral cavity. These lesions commonly cause bleeding from the nasal cavity.

R. seeberi can also affect the lacrimal gland and also rarely the skin and genitalia.

Common sites affected:

  1. Nose – 78%
  2. Nasopharynx – 68%
  3. Tonsil – 3%
  4. Eye – 1%
  5. Skin – very rare

Treatment

Treatment is generally by surgical removal of the infected tissues. [3]

Povidone-iodine and antifungal drugs such as amphotericin B, dapsone, and silver nitrate have been suggested as possible antiseptics. [16]

See also

Related Research Articles

<span class="mw-page-title-main">Infection</span> Invasion of an organisms body by pathogenic agents

An infection is the invasion of tissues by pathogens, their multiplication, and the reaction of host tissues to the infectious agent and the toxins they produce. An infectious disease, also known as a transmissible disease or communicable disease, is an illness resulting from an infection.

<i>Fusobacterium</i> Genus of bacteria

Fusobacterium is a genus of obligate anaerobic, Gram-negative, non-sporeforming bacteria belonging to Gracilicutes. Individual cells are slender, rod-shaped bacilli with pointed ends. Fusobacterium was discovered in 1900 by Courmont and Cade and is common in the flora of humans.

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. They are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. The economic impact of tick-borne diseases is considered to be substantial in humans, and tick-borne diseases are estimated to affect ~80 % of cattle worldwide. Most of these pathogens require passage through vertebrate hosts as part of their life cycle. Tick-borne infections in humans, farm animals, and companion animals are primarily associated with wildlife animal reservoirs. Many tick-borne infections in humans involve a complex cycle between wildlife animal reservoirs and tick vectors. The survival and transmission of these tick-borne viruses are closely linked to their interactions with tick vectors and host cells. These viruses are classified into different families, including Asfarviridae, Reoviridae, Rhabdoviridae, Orthomyxoviridae, Bunyaviridae, and Flaviviridae.

<i>Corynebacterium diphtheriae</i> Species of prokaryote

Corynebacterium diphtheriae is a gram-positive pathogenic bacterium that causes diphtheria. It is also known as the Klebs–Löffler bacillus because it was discovered in 1884 by German bacteriologists Edwin Klebs (1834–1912) and Friedrich Löffler (1852–1915). The bacteria are usually harmless unless they are infected by a bacteriophage that carries a gene that gives rise to a toxin. This toxin causes the disease. Diphtheria is caused by the adhesion and infiltration of the bacteria into the mucosal layers of the body, primarily affecting the respiratory tract and the subsequent release of an exotoxin. The toxin has a localized effect on skin lesions, as well as a metastatic, proteolytic effects on other organ systems in severe infections. Originally a major cause of childhood mortality, diphtheria has been almost entirely eradicated due to the vigorous administration of the diphtheria vaccination in the 1910s.

<span class="mw-page-title-main">Ichthyosporea</span> Clade of eukaryote organisms

The Ichthyosporea are a small group of Opisthokonta in Eukaryota, mostly parasites of fish and other animals.

<i>Campylobacter fetus</i> Species of bacterium

Campylobacter fetus is a rod-shaped, gram-negative species of bacteria within the genus Campylobacter of phylum Pseudomonadota. Identification of C. fetus species in infected animals or people is routinely performed by culture on blood or cefoperazone deoxycholate agar. Subspecies of C. fetus commonly causes reproductive disease in ruminants and gastrointestinal disease in humans. Transmission of C. fetus subspecies venerealis occurs mainly through venereal contact while transmission of C. fetus subspecies fetus occurs mainly through ingestion of bacteria in a contaminated environment. Infertility in cattle and abortion in sheep are common outcomes of infection associated with C. fetus subspecies venerealis and C. fetus subspecies fetus, respectively. Disease in humans occurs through zoonotic transmission of C. fetus mainly via ingestion of contaminated food or water sources. C. fetus can be diagnosed with polymerase chain reaction assays, enzyme linked immunosorbent assays and vaginal mucus agglutination testing. As vaccines are typically not efficient in preventing future spread, infected bulls are often culled. Human infections may be treated with erythromycin as antimicrobial resistance has been emerging for the fluoroquinolones.

An emergent virus is a virus that is either newly appeared, notably increasing in incidence/geographic range or has the potential to increase in the near future. Emergent viruses are a leading cause of emerging infectious diseases and raise public health challenges globally, given their potential to cause outbreaks of disease which can lead to epidemics and pandemics. As well as causing disease, emergent viruses can also have severe economic implications. Recent examples include the SARS-related coronaviruses, which have caused the 2002–2004 outbreak of SARS (SARS-CoV-1) and the 2019–2023 pandemic of COVID-19 (SARS-CoV-2). Other examples include the human immunodeficiency virus, which causes HIV/AIDS; the viruses responsible for Ebola; the H5N1 influenza virus responsible for avian influenza; and H1N1/09, which caused the 2009 swine flu pandemic. Viral emergence in humans is often a consequence of zoonosis, which involves a cross-species jump of a viral disease into humans from other animals. As zoonotic viruses exist in animal reservoirs, they are much more difficult to eradicate and can therefore establish persistent infections in human populations.

Relapsing fever is a vector-borne disease caused by infection with certain bacteria in the genus Borrelia, which is transmitted through the bites of lice, soft-bodied ticks, or hard-bodied ticks.

<i>Eikenella corrodens</i> Species of bacterium

Eikenella corrodens is a Gram-negative facultative anaerobic bacillus that can cause severe invasive disease in humans. It was first identified by M. Eiken in 1958, who called it Bacteroides corrodens. E. corrodens is a rare pericarditis associated pathogen. It is a fastidious, slow growing, human commensal bacillus, capable of acting as an opportunistic pathogen and causing abscesses in several anatomical sites, including the liver, lung, spleen, and submandibular region. E. corrodens could independently cause serious infection in both immunocompetent and immunocompromised hosts.

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

Mycoplasma ovipneumoniae is a species of Mycoplasma bacteria that most commonly inhabits and affects ovine animals, first described in 1972. M. ovipneumoniae contributes to harmful pneumonia in sheep and goats. The duration and severity of M. ovipneumoniae varies from region to region.

<i>Blastomyces dermatitidis</i> Species of fungus

Blastomyces dermatitidis is a dimorphic fungus that causes blastomycosis, an invasive and often serious fungal infection found occasionally in humans and other animals. It lives in soil and wet, decaying wood, often in an area close to a waterway such as a lake, river or stream. Indoor growth may also occur, for example, in accumulated debris in damp sheds or shacks. The fungus is endemic to parts of eastern North America, particularly boreal northern Ontario, southeastern Manitoba, Quebec south of the St. Lawrence River, parts of the U.S. Appalachian mountains and interconnected eastern mountain chains, the west bank of Lake Michigan, the state of Wisconsin, and the entire Mississippi Valley including the valleys of some major tributaries such as the Ohio River. In addition, it occurs rarely in Africa both north and south of the Sahara Desert, as well as in the Arabian Peninsula and the Indian subcontinent. Though it has never been directly observed growing in nature, it is thought to grow there as a cottony white mold, similar to the growth seen in artificial culture at 25 °C (77 °F). In an infected human or animal, however, it converts in growth form and becomes a large-celled budding yeast. Blastomycosis is generally readily treatable with systemic antifungal drugs once it is correctly diagnosed; however, delayed diagnosis is very common except in highly endemic areas.

Lacazia is a genus of fungi containing the single species Lacazia loboi, which is responsible for Lobo's disease. It is a member of the order Onygenales.

<span class="mw-page-title-main">Rhinosporidiosis</span> Medical condition

Rhinosporidiosis is an infection caused by Rhinosporidium seeberi.

Pneumococcal infection is an infection caused by the bacterium Streptococcus pneumoniae.

Sphaerothecum destruens is a parasite of fish. It was first discovered in the United States in association with invasive species including topmouth gudgeon, but was found to be the causative agent of a disease in the UK affecting salmonid species such as Atlantic salmon and brown trout. It is thought to pose more of a risk in Europe than in the US, as native species there are more susceptible to the parasite. The disease causes high rates of morbidity and mortality in a number of different salmonid species and can also infect other UK freshwater fish such as bream, carp, and roach. The genus Sphaerothecum is closely related to the genera Dermocystidium and Rhinosporidium.

<i>Aeromonas salmonicida</i> Species of bacterium

Aeromonas salmonicida is a pathogenic bacterium that severely impacts salmonid populations and other species. It was first discovered in a Bavarian brown trout hatchery by Emmerich and Weibel in 1894. Aeromonas salmonicida's ability to infect a variety of hosts, multiply, and adapt, make it a prime virulent bacterium. A. salmonicida is an etiological agent for furunculosis, a disease that causes sepsis, haemorrhages, muscle lesions, inflammation of the lower intestine, spleen enlargement, and death in freshwater fish populations. It is found worldwide with the exception of South America. The major route of contamination is poor water quality; however, it can also be associated stress factors such as overcrowding, high temperatures, and trauma. Spawning and smolting fish are prime victims of furunculosis due to their immunocompromised state of being.

In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.

Staphylococcus pseudintermedius is a gram positive coccus bacteria of the genus Staphylococcus found worldwide. It is primarily a pathogen for domestic animals, but has been known to affect humans as well. S. pseudintermedius is an opportunistic pathogen that secretes immune modulating virulence factors, has many adhesion factors, and the potential to create biofilms, all of which help to determine the pathogenicity of the bacterium. Diagnoses of Staphylococcus pseudintermedius have traditionally been made using cytology, plating, and biochemical tests. More recently, molecular technologies like MALDI-TOF, DNA hybridization and PCR have become preferred over biochemical tests for their more rapid and accurate identifications. This includes the identification and diagnosis of antibiotic resistant strains.

A nasal vaccine is a vaccine administered through the nose that stimulates an immune response without an injection. It induces immunity through the inner surface of the nose, a surface that naturally comes in contact with many airborne microbes. Nasal vaccines are emerging as an alternative to injectable vaccines because they do not use needles and can be introduced through the mucosal route. Nasal vaccines can be delivered through nasal sprays to prevent respiratory infections, such as influenza.

References

  1. "Rhinosporidium A.Minchin & H.Fantham, 1905". Global Biodiversity Information Facility . Retrieved 10 January 2024.
  2. 1 2 Berrocal, Alexis; López, Alfonso (March 2007). "Nasal rhinosporidiosis in a mule". The Canadian Veterinary Journal. 48 (3): 305–306. PMC   1800950 . PMID   17436910.
  3. 1 2 3 Morelli, Luca; Polce, Mario; Piscioli, Francesco; Del Nonno, Franca; Covello, Renato; Brenna, Alessia; Cione, Antonio; Licci, Stefano (December 2006). "Human nasal rhinosporidiosis: an Italian case report". Diagnostic Pathology. 1 (1): 25. doi: 10.1186/1746-1596-1-25 . PMC   1560165 . PMID   16945122.
  4. V, Thankamani (June 2005). "Rhinosporidium Seeberi Grown in Culture" (PDF). Sajosps: 118–123.
  5. Thankamani, V; Lipin-Dev, MS (2011). "Demonstration of viability and development stages of 10 years old refrigerated culture of Rhinosporidium seeberi (?) UMH. 48 first ever isolated from nasal Rhinosporidiosis yet another milestone, a tribute to Guillermo Seeber". IJPI's Journal of Biotechnology and Biotherapeutics. 1: 11–21.[ unreliable source? ]
  6. 1 2 Raquel, Vilela; Leonel Mendoza (October 2012). "The taxonomy and phylogenetics of the human and animal pathogen Rhinosporidium seeberi: A critical review". Revista Iberoamericana de Micología. 29 (4): 185–199 [190]. doi:10.1016/j.riam.2012.03.012. PMID   22504725.
  7. Arseculeratne, Sarath N; Atapattu, Dhammika N. (2011). Rhinosporidiosis in Humans and Animals & Rhinosporidium seeberi. Faculty of Medicine, University of Peradeniya. ISBN   978-955-589-157-8.[ page needed ]
  8. Arseculeratne, Sarath Nanda (April 2005). "Rhinosporidiosis: what is the cause?". Current Opinion in Infectious Diseases. 18 (2): 113–118. doi:10.1097/01.qco.0000160898.82115.e8. PMID   15735413. S2CID   38343304.
  9. Fredricks, D N; Jolley, J A; Lepp, P W; Kosek, J C; Relman, D A (2000). "Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites". Emerging Infectious Diseases. 6 (3): 273–282. doi:10.3201/eid0603.000307. PMC   2640875 . PMID   10827117.
  10. Arseculeratne, Sn (July 2002). "Recent Advances in Rhinosporidiosis and Rhinosporidium Seeberi". Indian Journal of Medical Microbiology. 20 (3): 119–131. doi:10.1016/S0255-0857(21)03243-6. PMID   17657050.
  11. Herr, Roger A.; Ajello, Libero; Taylor, John W.; Arseculeratne, Sarath N.; Mendoza, Leonel (September 1999). "Phylogenetic Analysis of Rhinosporidium seeberi 's 18S Small-Subunit Ribosomal DNA Groups This Pathogen among Members of the Protoctistan Mesomycetozoa Clade". Journal of Clinical Microbiology. 37 (9): 2750–2754. doi:10.1128/JCM.37.9.2750-2754.1999. PMC   85368 . PMID   10449446.
  12. 1 2 Silva, Victor; Pereira, Cristiane N.; Ajello, Libero; Mendoza, Leonel (April 2005). "Molecular Evidence for Multiple Host-Specific Strains in the Genus Rhinosporidium". Journal of Clinical Microbiology. 43 (4): 1865–1868. doi:10.1128/JCM.43.4.1865-1868.2005. PMC   1081358 . PMID   15815010.
  13. Weller, Carl Vernon; Riker, Aaron D. (November 1930). "Rhinosporidium Seeberi: Pathological Histology and Report of the Third Case from the United States". The American Journal of Pathology. 6 (6): 721–732.11. PMC   2007358 . PMID   19969938.
  14. Hoff, B.; Hall, D. A. (June 1986). "Rhinosporidiosis in a Dog". The Canadian Veterinary Journal. 27 (6): 231–232. PMC   1680264 . PMID   17422665.
  15. Kumara Kaluarachchi; Saranga Sumathipala; Navaratne Eriyagama; Dhammika Atapattu; Sarath Arseculeratne (2008). "The Identification of the Natural Habitat of Rhinosporidium seeberi with R. seeberi—Specific in situ Hybridization Probes" (PDF). J Infect Dis Antimicrob Agents. 25 (1). Infectious Disease Association of Thailand: 25–32.
  16. Arseculeratne, SN; Atapattu, DN; Balasooriya, P; Fernando, R (April 2006). "The Effects of Biocides (Antiseptics and Disinfectants) on the Endospores of Rhinosporidium Seeberi". Indian Journal of Medical Microbiology. 24 (2): 85–91. doi: 10.1016/S0255-0857(21)02404-X .